News

2018 Jan 05

Peter Martin, M.D., Talks Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL

Video of Dr. Martin on Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL Peter Martin, M.D., discusses a trial of the combination of oral azacitidine (CC-486) and R-CHOP in diffuse large B-cell lymphoma (DLBCL). This... Read more

2017 Dec 28

The Value of MIPI and Ki-67 in Mantle Cell Lymphoma

Video of The Value of MIPI and Ki-67 in Mantle Cell Lymphoma John P. Leonard, M.D., interim chair of the Department of Medicine, associate dean of clinical research, Richard T. Silver Distinguished Professor of Hematology... Read more

2017 Dec 11

Signs of acute myeloid leukemia may be present years before diagnosis

Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis , according to research from Weill Cornell... Read more

2017 Dec 06

Silvia C. Formenti, M.D., Gives Keynote Lecture at the 2017 San Antonio Breast Cancer Symposium

Video of Keynote Lecture: Silvia C. Formenti, MD, on Converting Tumors Into in Situ Vaccines With Radiation Therapy In her keynote lecture at the 2017 San Antonio Breast Cancer Symposium, Silvia C. Formenti, M.D., Professor... Read more

2017 Nov 30

Dan A. Landau, M.D., Ph.D., Receives the the 2017 Joanne Levy, M.D., Memorial Award for Outstanding Achievement from the American Society of Hematology

Dan A. Landau, M.D., Ph.D., assistant professor of m edicine in hematology/oncology and assistant professor in physiology and biophysics, will receive the 2017 Joanne Levy, M.D., Memorial Award for Outstanding Achievement... Read more

Jessica Tyler, epigenetics, genetics, chromatin, cancer

2017 Nov 20

Jessica Tyler, Ph.D., Elected Fellow of AAAS

Dr. Jessica Tyler , who was recruited to Weill Cornell Medicine as a professor of pathology and laboratory medicine, has been elected a fellow of the American Association for the Advancement of Science (AAAS). Dr. Tyler was... Read more

2017 Nov 20

Mark M. Souweidane, M.D., Named to NCI’s Brain Malignancies Steering Committee

Mark Souweidane, M.D., has been selected by the National Cancer Institute (NCI) to serve as a member of its Brain Malignancies Steering Committee (BMSC). The committee is charged with reviewing and prioritizing Phase 2 and... Read more

2017 Nov 17

Todd Evans, Ph.D., Talks Cancer Organoids with the Daily Beast

Would you trust a 3D-printed mini organ to test your drugs? The Daily Beast's article on the matter features the perspective of Todd Evans, Ph.D., Associate Dean for Research. Read more

2017 Oct 27

L.A. Times Op-Ed Features MCC Director Lewis Cantley, Ph.D.

Science journalist Sam Apple interviewed Dr. Lewis Cantley for his opinion piece in the Los Angeles Times on the connection between sugar and cancer. Read more

a woman smiling for a portrait in front of an mri

2017 Oct 18

Shining a Light

When Dr. Onyinye Balogun was a young girl, her father’s only sister was diagnosed with breast cancer back home in their native Nigeria. Dr. Balogun had recently immigrated to the United States with her parents, but on a... Read more

2017 Oct 12

Ana Gomes, Ph.D., Selected as a 2017 STAT Wunderkind

As you get older, your risk of developing cancer increases. That might seem obvious, but Ana Gomes, Ph.D., wants to know why. She’s studying a chemical, found more prominently in older people than young, and how it may be... Read more

2017 Oct 06

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer... Read more

2017 Oct 05

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

NEW YORK (October 5, 2017) — Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s... Read more

2017 Oct 05

MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards

Two of the 2017 Prostate Cancer Foundation (PCF) Challenge Awards were awarded to teams including Meyer Cancer Center investigators. Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation ($1 million): Scott... Read more

2017 Oct 02

American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,

American Society of Hematology (ASH) announced the names of five investigators whose research has been awarded $150,000 through the ASH Bridge Grant Program. Meyer Cancer Center member Selina Chen-Kiang, Ph.D. was one of the... Read more

2017 Sep 27

The Differences Between Right- and Left-Sided Tumors in Colon Cancer

Video of The Differences Between Right- and Left-Sided Tumors in Colon Cancer Manish A. Shah, M.D., discusses the differences between right- and left-sided colon cancer. Read more

2017 Sep 21

How A Liquid Biopsy Changes Cancer Treatment

David Nanus, M.D., and Scott Tagawa, M.D., M.S., speak to Fox 5 News about liquid biopsies in cancer treatment. Read more

2017 Sep 21

Metastatic Breast Cancer Affects Bone Mineral Before Spreading

This article by Tom Fleischman first appeared in the Cornell Chronicle . When breast cancer metastasizes, or spreads, one of its most likely destinations is bone. In fact, four in five metastatic breast cancer patients will... Read more

2017 Sep 19

Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit

A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more

2017 Sep 18

Epigenetic Code Plays a Role in Acute Myeloid Leukemia

This article by Bridget Kuehn first appeared in the Cornell Chronicle . Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment... Read more

Peter Martin, M.D., Talks Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL

The Value of MIPI and Ki-67 in Mantle Cell Lymphoma

Signs of acute myeloid leukemia may be present years before diagnosis

Silvia C. Formenti, M.D., Gives Keynote Lecture at the 2017 San Antonio Breast Cancer Symposium

Dan A. Landau, M.D., Ph.D., Receives the the 2017 Joanne Levy, M.D., Memorial Award for Outstanding Achievement from the American Society of Hematology

Jessica Tyler, Ph.D., Elected Fellow of AAAS

Mark M. Souweidane, M.D., Named to NCI’s Brain Malignancies Steering Committee

Todd Evans, Ph.D., Talks Cancer Organoids with the Daily Beast

L.A. Times Op-Ed Features MCC Director Lewis Cantley, Ph.D.

Shining a Light

Ana Gomes, Ph.D., Selected as a 2017 STAT Wunderkind

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

Neuro-Oncologist Dr. Howard Fine Wins NIH Director’s Pioneer Award

MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards

American Society of Hematology Bridge Grant Awarded to Selina Chen-Kiang, Ph.D.,

The Differences Between Right- and Left-Sided Tumors in Colon Cancer

How A Liquid Biopsy Changes Cancer Treatment

Metastatic Breast Cancer Affects Bone Mineral Before Spreading

Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit

Epigenetic Code Plays a Role in Acute Myeloid Leukemia

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters